Washington, DC 20006-5349
HELPLINE
Today, the Mesothelioma Applied Research Foundation (Meso Foundation) announced the award recipients of its 2018 grant cycle funding for promising mesothelioma research. About the Mesothelioma…
The Fiscal Year 2019 (FY19) funding bill for the U.S. Department of Health and Human Services (HHS) that Congress passed in September includes $100,000 for a feasibility study, the first step in the development of a National Mesothelioma Patient Registry. This funding will be provided through the Centers for Disease Control…
The Mesothelioma Applied Research Foundation (Meso Foundation) announced today that William (Bill) N. Ziegler has been elected to join its board of directors. He will…
Valerie W. Rusch, MD, FACS, a respected thoracic surgeon at Memorial Sloan Kettering Cancer Center (MSKCC), was recently elected by her peers to the prestigious…
For the first time in mesothelioma, a group of researchers sequenced the genome of 74 malignant pleural mesothelioma tumors. According to the authors, the study…
UPDATE: As of May 2019, the device Optune Lua, formerly known as NovoTTF-100L, was approved by the FDA under the Humanitarian Device Exemption (HDE) in…
Today was a big day for immunotherapy news. Two studies we have been following closely have released their final data analyses, plus we learned that…
With only one FDA-approved treatment for mesothelioma (a chemotherapy combination of Alimta (pemetrexed) and cisplatin), most advances in mesothelioma treatment are still considered experimental. As…
Mesothelioma is not lung cancer, but many experts who treat mesothelioma also treat lung cancer. Therefore, this enormous conference which often boasts 7,000 to 8,000…
We are deeply saddened by the passing of Dr. David Sugarbaker, a beloved mesothelioma surgeon and researcher. He leaves a huge void in the mesothelioma…
Get the latest information about mesothelioma, clinical trials, patient stories, community events, and much more!
